NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Share Price Passes Above 200 Day Moving Average – Time to Sell?

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UNGet Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$4.94 and traded as high as C$5.02. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.95, with a volume of 971,901 shares trading hands.

Analyst Ratings Changes

Separately, National Bankshares lifted their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 and gave the company an “outperform” rating in a research report on Tuesday, March 11th.

Read Our Latest Analysis on NWH.UN

NorthWest Health Prop Real Est Inv Trust Stock Performance

The company has a debt-to-equity ratio of 129.42, a quick ratio of 0.06 and a current ratio of 0.25. The business’s fifty day moving average price is C$4.84 and its two-hundred day moving average price is C$4.94. The stock has a market capitalization of C$1.16 billion, a P/E ratio of -2.96, a P/E/G ratio of 0.74 and a beta of 1.05.

About NorthWest Health Prop Real Est Inv Trust

(Get Free Report)

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.

Recommended Stories

Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.